Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Biologics Testing Market: By Product Type, By Test, By Application, By Geography.
Biologics Testing Market: By Product Type, By Test, By Application, By Geography.
Biologics Testing Market size was valued at US$ 3.2 Bn in 2023, growing at a significant CAGR of 11.8% from 2024-2030. The biologics testing market report provides in-depth analysis of the impact of COVID-19 on the market, along with revised biologics testing market size due to the effects of the coronavirus. The increase in R&D investment in biopharma industry coupled with the increase in the new product launches are expected to bolster the market growth over the forecast period.Biologics are complex compounds made from the genes of live creatures and combined utilising modern DNA technologies. Biologics are cutting-edge medications that are used to treat cancer, cardiovascular disease, rheumatoid arthritis, and other illnesses.
Large molecules such as monoclonal antibodies and recombinant proteins are classified as biologics, and their safety ensures patient safety because they are utilised to treat the diseases listed above. Recombinant proteins, tissues, genes, allergens, cells, blood components, and vaccinations are all examples of biologic medications made from live creatures. Biologics are items that are made from living organisms and have specific properties.For new product categories, biological safety assessment is critical. Biological safety testing is done to guarantee that vaccines and biopharmaceuticals are not contaminated and that they meet safety quality standards. Kits and reagents, as well as instruments, make up the product segment.
Study Period
2024-2030Base Year
2023CAGR
11.8%Largest Market
North AmericaFastest Growing Market
Europe
The biologics testing market is mainly driven by the strengthening of the regulatory procedures in many countries for the approval and marketing of the biological products. In addition, robust growth in biopharmaceutical industry and increase in prevalence of the diseases among the population expected to boost the market share.
Geographically, the biologics testing market is segmented into North America, Europe, Middle East and Africa, Asia Pacific and Latin America. North America biologics testing market expected to have the significant share and growth rate owing to the factors such as presence of major biological companies, increase in R&D related to the biologicals coupled with the favorable regulatory environment for the biological test service providers. Europe biologics testing market projected to grow at notable rates owing to the high growth rate of biopharmaceutical industryand growing prevalence of the various diseases intern stimulating the development of new biopharmaceuticals. Asia Pacific region projected to have lucrative growth opportunity over the forecast period owing to the low cost of production and labor, development of healthcare infrastructure and increase in medical spending by the population.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market CAGR |
11.8% |
|
By Product Type |
|
|
By Application |
|
|
By Test |
|
|
By Region |
|
Download Free Sample Report
The key segments covered in the biologics testing market are: by Product Type, by Test, by Application
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.